A 64-year-old man was admitted for epigastralgia. Abdominal CT showed an enhanced tumor at the lower biliary duct causing obstructive jaundice. Tumor cells with high nuclear-cytoplasmic (N/C) ratio and rosette formation were confirmed by biopsy. Immunostaining findings were positive for chromogranin A,synaptophysin, and neuron specific enolase. Preoperatively, we suspected neuroendocrine carcinoma (NEC) of the bile duct, and performed subtotal stomach-preserving pancreatoduodenectomy. Histological examination of the specimen demonstrated large cell NEC of the bile duct. The Ki-67 index was 40%. As adjuvant chemotherapy, tegafur-gimeracil-oteracil potassium was administered for 24 months, and he has no evidence of recurrence after surgery. NEC of the bile duct are rare and highly malignant diseases with a dismal prognosis. To the best of our knowledge, 50 cases of biliary NEC have been reported in Japan, and only 6 cases of biliary large cell NEC have been reported in the English literature. Analysis of reported cases indicates that curative resection can improve survival rate among patients with biliary NEC. Further evaluation is needed to elucidate optimal adjuvant therapy for biliary NEC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.